News from tessa therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 10, 2021, 06:12 ET Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial

Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies...

Jan 18, 2021, 06:00 ET Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy

Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and...

Dec 17, 2020, 09:27 ET Tessa Therapeutics Appoints David McIntyre as Chief Financial Officer

Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced the appointment of...

Aug 06, 2020, 07:00 ET Tessa Therapeutics Announces Results from Two Independent Phase 1/2 Trials of Autologous CD30 CAR-T Cell Therapy in Patients with Relapsed or Refractory Hodgkin Lymphoma

Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced the publication of...

May 04, 2020, 12:00 ET Tessa Therapeutics Announces New Executive Leadership

Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced that Jeffrey H....

Feb 27, 2020, 07:00 ET Tessa Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to its CD30 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory CD30-positive Classical Hodgkin Lymphoma

Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced that the Company's...

Dec 19, 2019, 07:00 ET Tessa Therapeutics to Open 90,000 Square Foot Commercial-Scale Cell Therapy Manufacturing Facility in Singapore in 2020

Tessa Therapeutics (Tessa), a clinical-stage cell therapy company focused on the development of innovative cell therapies to treat cancer, today...

Jun 12, 2019, 19:15 ET Tessa Therapeutics and China-Singapore Guangzhou Knowledge City Form Landmark US$120 Million Joint Venture in China to Develop Innovative Cell Therapies for Cancer

Tessa Therapeutics (Tessa), a clinical-stage cell therapy company focused on the development of autologous and allogeneic therapies to treat cancer,...

Apr 30, 2019, 10:00 ET Tessa Therapeutics, in Collaboration with Baylor College of Medicine, Presents Preclinical Results Showing Enhanced T Cell Responses Against HER2-Positive Solid Tumors Using Novel Combination CAR T Cell Therapy

Tessa Therapeutics, a clinical-stage cell therapy company focused on autologous and allogeneic therapies for a wide range of cancers, today announced ...

Apr 15, 2019, 19:15 ET Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer

Tessa Therapeutics, a clinical-stage immunotherapy company focused on autologous and off-the-shelf, allogeneic therapies targeting solid tumors,...

Feb 28, 2019, 18:15 ET Tessa Therapeutics Names Biopharma Veteran Jeffrey H. Buchalter to Board of Directors

Tessa Therapeutics, a clinical-stage immunotherapy company focused on autologous and off-the-shelf, allogeneic therapies targeting solid tumors,...

Dec 20, 2018, 19:41 ET Distinguished Breast Cancer Expert, Dr. George W. Sledge, Jr., M.D., to join the Board of Tessa Therapeutics

Tessa Therapeutics, a clinical-stage immunotherapy company focused on autologous and off-the-shelf, allogeneic therapies for cancer patients, today...

Sep 20, 2018, 19:26 ET St. Jude Children's Research Hospital and Tessa Therapeutics Announce Strategic Collaboration

St. Jude Children's Research Hospital (St. Jude), the U.S. hospital leading the way the world understands, treats and cures childhood cancer and...

Apr 11, 2018, 07:00 ET Tessa Therapeutics announces new Board Member and increase of recent funding round

Tessa Therapeutics, an international clinical stage biopharmaceutical company focusing on cellular immunotherapy treatments for cancer, is delighted...

Feb 05, 2018, 07:00 ET Tessa Therapeutics Announces Opening of Recruitment Sites Across the United States for its Phase III Nasopharyngeal Cancer Immunotherapy Trial

Tessa Therapeutics (Tessa), a clinical stage immunotherapy company, announced that the Stanford Cancer Institute recently joined the company's trial...

Dec 19, 2017, 16:00 ET Tessa Therapeutics Closes USD 80 Million Financing Round Led by Temasek

Tessa Therapeutics, an international clinical stage biopharmaceutical company focusing on T cell therapy for solid tumors, today announced the...

Dec 11, 2017, 19:00 ET Tessa Therapeutics Appoints Mr. Desmond Lim as Chief Financial Officer

Tessa Therapeutics, a clinical stage biopharmaceutical company focusing on cellular immunotherapy treatments for solid tumors, today announces the...

Jun 19, 2017, 06:01 ET Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Strategic Alliance Agreement

Tessa Therapeutics (Tessa) and the Parker Institute for Cancer Immunotherapy (Parker Institute) today announced the establishment of a multi-year...